- Previous Close
0.1020 - Open
0.0980 - Bid 0.0950 x --
- Ask 0.1010 x --
- Day's Range
0.0900 - 0.0980 - 52 Week Range
0.0750 - 0.1700 - Volume
121,000 - Avg. Volume
346,215 - Market Cap (intraday)
16.417M - Beta (5Y Monthly) 0.19
- PE Ratio (TTM)
9.60 - EPS (TTM)
0.0100 - Earnings Date --
- Forward Dividend & Yield 0.00 (2.92%)
- Ex-Dividend Date Nov 7, 2023
- 1y Target Est
--
Singapore Paincare Holdings Limited, an investment holding company, operates medical clinics in Singapore. It offers pain care services for the treatment of patients suffering from acute and chronic pain due to injury, age-related pain conditions, functional pain disorders, post-surgical pain, and cancer pain, including minimally invasive and specialised injections, pharmacotherapy, and cognitive behavioural therapy. The company also offers specialist and surgical care services, which include dermatology, general surgery, orthopaedics, and musculoskeletal and sports medicine services; and associate specialist panel services, comprising cardiology, ENT, neurology, neurosurgery, ophthalmology, urology, and orthopaedic surgeon services. In addition, it provides rehabilitive care and wellness services, which comprise physiotherapy and traditional Chinese medicine; health, executive health, cancer screening services; and corporate healthcare services. Further, the company offers consultancy services for healthcare organisations. It operates five specialist clinics, eleven general practitioner clinics, one traditional Chinese medicine centre, and two physiotherapy centre. The company was founded in 2007 and is based in Singapore.
sgpaincare.comRecent News: FRQ.SI
View MorePerformance Overview: FRQ.SI
Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is STI Index (^STI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FRQ.SI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FRQ.SI
View MoreValuation Measures
Market Cap
16.42M
Enterprise Value
21.22M
Trailing P/E
11.43
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.60
Price/Book (mrq)
0.72
Enterprise Value/Revenue
0.78
Enterprise Value/EBITDA
3.77
Financial Highlights
Profitability and Income Statement
Profit Margin
5.13%
Return on Assets (ttm)
4.23%
Return on Equity (ttm)
8.71%
Revenue (ttm)
28.24M
Net Income Avi to Common (ttm)
1.45M
Diluted EPS (ttm)
0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
7.31M
Total Debt/Equity (mrq)
49.77%
Levered Free Cash Flow (ttm)
1.78M